A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis
NCT02193815
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis Vulgaris
Interventions
DRUG:
PF06263276
OTHER:
Vehicle
DRUG:
2%Tofacitinib Ointment
OTHER:
Vehicle
DRUG:
Daivonex
DRUG:
Daivonex Ointment
Sponsor
Pfizer